The clinical application of PET/CT: A contemporary review

Australasian Physical and Engineering Sciences in Medicine

Volumn 31, Issue 2, 2008, Pages 90-109

  Brady, Z ^a,b   Taylor, M L ^a,b   Haynes, M ^a,b   Whitaker, M ^b,c   Mullen, A ^b,d   Clews, L ^b,e   Partridge, M ^f   Hicks, R J ^d   Trapp, J V ^g  

^a ALFRED HOSPITAL   (Australia)

^b RMIT UNIVERSITY   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^d PETER MACCALLUM CANCER CENTRE   (Australia)

^e CALVARY MATER NEWCASTLE HOSPITAL   (Australia)

^f INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^g QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Applications; Oncology; PET CT; Treatment planning

Indexed keywords

APPLICATIONS; DIAGNOSIS; ONCOLOGY; PATIENT TREATMENT; POSITRON EMISSION TOMOGRAPHY; SCANNING;

ATTENUATION CORRECTION; CLINICAL APPLICATION; LITERATURE REVIEWS; PATIENT MANAGEMENT; POSITRON EMISSION TOMOGRAPHY SCANNERS; RADIOTHERAPY TREATMENT PLANNING; TREATMENT PLANNING; X-RAY COMPUTED TOMOGRAPHY;

COMPUTERIZED TOMOGRAPHY;

CHOLINE C 11; FLUOROCHOLINE F 18; FLUORODEOXYGLUCOSE; RADIOPHARMACEUTICAL AGENT;

ARTIFACT; BIOMEDICAL TECHNOLOGY ASSESSMENT; BREAST CANCER; CANCER RADIOTHERAPY; CANCER STAGING; COLORECTAL CANCER; COMPTON EFFECT; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIGESTIVE SYSTEM CANCER; EQUIPMENT DESIGN; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HODGKIN DISEASE; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; PROSTATE CANCER; RADIATION ATTENUATION; REVIEW; SENSITIVITY AND SPECIFICITY; SPINE METASTASIS; TREATMENT PLANNING; TUMOR VOLUME;

EID: 48049123043     PISSN: 01589938     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03178584     Document Type: Review

References (146)

1. O'Connor, M. K. and Kemp, B. J., Single-photon emission computed tomography/computed tomography: basic instrumentation and innovations, Semin. Nucl. Med., 36: 258-266, 2006.
2. Ambrose, J. and Hounsfield, G. N., Computerized transverse axial tomography, BJR., 46: 148-149, 1973.
3. Hounsfield, G. N., Computerized transverse axial scanning (tomography): Part I. Description of system, BJR., 46: 1016-1022, 1973.
4. Muehllehner, G. and Karp, J. S., Positron emission tomography, Phys. Med. Biol., 51: R117-R137, 2006.
5. Townsend, D., Beyer, T., Kinahan, P. E., Brun, T., Roddy, R., Nutt, R. and Byars, G., The SMART Scanner: a Combined PET/CT Tomograph for Clinical Oncology, IEEE Nucl. Sci. Symp. Conf. Rec., 1170, 1998.
6. Beyer, T., Townsend, D. W., Brun, T., Kinahan, P. E., Charron, M., Roddy, R., Jerin, J., Young, J., Byars, L. and Nutt, R., A Combined PET/CT Scanner for Clinical Oncology, J. Nucl. Med., 41: 1369-1379, 2000.
7. Tai, Y.-C., Chatziioannou, A. F., Yang, Y., Silverman, R. W., Meadors, K., Siegel, S., Newport, D. F., Stickel, J. R. and Cherry, S. R., MicroPET II: design, development and initial performance of an improved microPET scanner for small animal-imaging, Phys. Med. Biol., 48: 1519-1537, 2003.
8. Yang, Y., Tai, Y.-C., Siegel, S., Newport, D. F., Bai, B., Li, Q., Leahy, R. M. and Cherry, S. R., Optimization and performance evaluation of the microPETII scanner for in vivo small-animal imaging, Phys. Med. Biol., 49: 2527-2545, 2004.
9. Liang, H., Yang, Y., Yang, K., Wu, Y., Boone, J. M. and Cherry, S. R., A microPET/CT system for in vivo small animal imaging, Phys. Med. Biol., 52: 3881-3894, 2007.
10. Kalender, W. A., Computed Tomography: Fundamentals, System Technology, Image Quality, Applications, 2nd Edition, Wiley-VCH, 13: 978-3895782169, 2004.
11. Wernick, M. N. and Aarsvold, J. N., Emission Tomography: The Fundamentals of PET and SPECT: The Fundamentals of Pet and Spect, Academic Press, 13: 978-0127444826, 2004.
12. Townsend, D. W., Multimodality imaging of structure and function, Phys. Med. Biol., 53: R1-R39, 2008.
13. Zanzonico, P., Positron emission tomography: a review of basic principles, scanner design and performance, and current systems, Semin. Nucl. Med., 34: 87-111, 2004.
14. Surti, S., Kuhn, A., Werner, M. E., Perkins, A. E., Kolthammer, J. and Karp, J. S., Performance of a Philips Gemini TF PET/CT Scanner with Special Consideration for Its Time-of-Flight Imaging Capabilities, J. Nucl. Med., 48: 471-480, 2007.
15. Karp, J. S., Surti, S., Daube-Witherspoon, M. E. and Muehllehner, G., Benefit of Time-of-Flight in PET: Experimental and Clinical Results, J. Nucl. Med., 49: 462-70, 2008.
16. Ohi, J. and Tonami, H., Investigation of a whole-body DOI-PETsystem, NIM A, 571: 223-226, 2007.
17. Pichler, B. J., Swann, B. K., Rochelle, J., Nutt, R. E., Cherry, S. R. and Siegel, S. B., Lutetium oxyorthosilicate block detector readout by avalanche photodiode arrays for high resolution animal PET, Phys. Med. Biol., 49: 4305-4319, 2004.
18. Pichler, B. J., Judenhofer, M. S., Catana, C., Walton, J. H., Kneilling, M., Nutt, R. E., Siegel, S. B., Claussen, C. D. and Cherry, S. R., Performance test of an LSO-APD Detector in a 7-T MRI Scanner for Simultaneous PET/MRI, J. Nucl. Med., 47: 639-647, 2006.
19. Yamamoto, S., Matsumoto, K. and Senda, M., Development of a GSO positron/single-photon imaging detector, Phys. Med. Biol., 51: 457-469, 2006.
20. Gies, M., Kalender, W. A., Wolf, H., Suess, C. and Madsen, M. T., Dose reduction in CT by anatomically adapted tube current modulation. I. Simulation studies, Med. Phys., 26: 2235-2247, 1999.
21. Kalender, W. A., Wolf, H. and Suess, C., Dose reduction in CT by anatomically adapted tube current modulation. II. Phantom measurements, Med. Phys., 26: 2248-2253, 1999.
22. Kinahan, P. E., Hasegawa, B. H. and Beyer, T., X-ray-based attenuation correction for positron emission tomography/computed tomography scanners, Semin. Nucl. Med., 33: 166-179, 2003.
23. Townsend, D. W., Carney, J. P. J., Yap, J. T. and Hall, N. C., PET/CT today and tomorrow, J. Nucl. Med. (suppl), 45: 4S-14S, 2004.
24. Beyer, T., Antoch, G., Muller, S., Egelhof, T., Freudenberg, L. S., Debatin, J. and Bockisch, A., Acquisition protocol considerations for combined PET/CT imaging, J. Nucl. Med. (suppl), 45: 24S-35S, 2004.
25. Alessio, A. M., Kinahan, P. E., Cheng, P. M., Vesselle, H. and Karp, J. S., PET/CT scanner instrumentation, challenges and solutions, Radiologic Clinics of North America, 42: 1017-1032, 2004.
26. Accorsi, R., Adam, L.-E., Werner, M. E. and Karp, J. S., Optimisation of a fully 3D single scatter simulation algorithm for 3D PET, Phys. Med. Biol., 49: 2577-2598, 2004.
27. Cheng, C.-C., Rahmim, A., Blinder, A., Camborde, M.-L., Raywood, K. and Sossi, V., A scatter-corrected list-mode reconstruction and a practical scatter/random approximation technique for dynamic PET imaging, Phys. Med. Biol., 52: 2089-2106, 2007.
28. Markiewicz, P. J., Tamal, M., Julyan, P. J., Hastings, D. L. and Reader, A. J., High Accuracy Multiple Scatter Modelling for 3D Whole Body PET, Phys. Med. Biol., 52: 829-247, 2007.
29. Ollinger, J. M., Model-based scatter correction for fully 3D PET, Phys. Med. Biol., 41: 153-176, 1996.
30. Goerres, G. W., Hany, T. F., Kamel, E., von Schulthess, G. K. and Buck, A., Head and neck imaging with PET and PET/CT: artefacts from dental metallic implants, Eur. J. Nuc. Med. Mol. Imag., 29: 367-370, 2002.
31. Cook, G. J. R., Wegner, E. A. and Fogelman, I., Pitfalls and Artifacts in 18FDG PET and PET/CT Oncologic Imaging, Semin. Nucl. Med., 34: 122-133, 2004.
32. Hamill, J. J., Brunken, R. C., Bybel, B., DiFilippo, F. P. and Faul, D. D., A knowledge-based method for reducing attenuation artefacts caused by cardiac appliances in myocardial PET/CT, Phys. Med. Biol., 51: 2901-2918, 2006.
33. Williamson, J. F., Whiting, B. R., Benac, J., Murphy, R. J., Blaine, G. J., O'Sullivan, A., Politte, D. G. and Snyder, D. L., Prospects for quantitative computed tomography imaging in the presence of foreign metal bodies using statistical image reconstruction, Med. Phys., 29: 2404-18, 2002.
34. Carney, J. P., Beyer, T., Brasse, D., Yap, J. T. and Townsend, D. W., Clinical PET/CT scanning using oral CT contrast agents, J. Nucl. Med. [abstract], 43: 57P, 2002.
35. Nehmeh, S. A., Erdi, Y. E., Kalaigian, H., Kolbert, K. S., Pan, T., Yeung, H., Squire, O., Sinha, A., Larson, S. M. and Humm, J. L., Correction for Oral Contrast Artifcats in CT Attenuation-Corrected PET Imagins Obtained by Combined PET/CT, J. Nucl. Med., 44: 1940-1944, 2003.
36. Antoch, G., Kuehl, H., Kanja, J., Lauenstein, T. C., Schneermann, H., Hauth, E., Jentzen, W., Beyer, T., Goehde, S. C. and Debatin, J. F., Dual-Modality PET/CT Scanning with Negative Oral Contrast Agent to Avoid Artifacts: Introduction and Evaluation, Radiology, 230: 879-885, 2004.
37. Yau, Y.-Y., Chan, W.-Z., Tam, Y.-M., Vernon, P., Wong, S., Coel, M. and Kwok-Fai Chu, S., Application of Intravenous Contrast in PET/CT: Does It Really Introduce Significant Attenuation Correction Error?, J. Nucl. Med., 46: 283-291, 2005.
38. Berthelsen, A. K., Holm, S., Klausen, T. L., Andersen, F. and Hojgaard, L., PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients, Eur. J. Nucl. Med. Mol. Imag., 32: 1167-1175, 2005.
39. Schoder, H., Erdi, Y. E., Larson, S. M. and Yeung, H. W. D., PET/CT: a new imaging technology in nuclear medicine, Eur. J. Nucl. Med. Mol. Imag., 30: 1419-1437, 2003.
40. Beyer, T., Bockisch, A., Kuhi, H. and Martinez, M.-J., Whole-Body 18F-FDG PET/CT in the Presence of Truncation Artifacts, J. Nucl. Med., 47: 91-99, 2006.
41. Gambir, S. S., Czernin, J., Schimmer, J., Silverman, D., Coleman, R. E. and Phelps, M. E., A Tabulated Summary of the FDG PET Literature, J. Nucl. Med. (suppl), 42: 1S-93S, 2001.
42. Czernin, J., Allen-Auerbach, M. and Schelbert, H. R., Improvements in Cancer Staging with PET/CT: Literature-based evidence as of Septebmer 2006, J. Nucl. Med., 48: 78S-88S, 2007.
43. Lardinois, D., Weder, W., Hany, T. F., Kamel, E. M., Korom, S., Seifert, B., von Schulthess, G. K. and Steinert, H. C., Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography, N. Engl. J. Med., 348: 2500-2507, 2003.
44. Bar-Shalom, R., Yefremov, N., Guralnik, L., Gaitini, D., Frenkel, A., Kuten, A., Altman, H., Keidar, Z. and Israel, O., Clinical Performance on PET/CT in Evaluation of Cancer: Additional Value for Diagnostic Imaging and Patient Management, J. Nucl. Med., 44: 1200-1200, 2003.
45. Antoch, G., Stattaus, J., Nemat, A. T., Marnitz, S., Beyer, T., Kuehl, H., Bocklsch, A., Debatin, J. F. and Freudenberg, L. S., Non-small Cell Lung Cancer: Dual Modality PET/CT in Preoperative Staging, Radiol, 229: 526, 2003.
46. Keidar, Z., Haim, N., Guralnik, L., Wollner, M., Bar-Shalom, R., Ben-Nun, A. and Israel, O., PET/CT using 18F-FDG in Suspected Lung Cancer Recurrence: Diagnostic Value and Impact on Patient Management, J. Nucl. Med., 45: 1640, 2004.
47. Wamena, B. A., Sonnad, S. S., Angobaldo, J. O. and Wahl, R. L., Metastases from non-small cell lung cancer: mediastinal staging in the 1990s - meta-analytic comparison of PET and CT, Radiol., 213: 530-536, 1999.
48. Kalff, V., Hicks, R. J., MacManus, M. P., Binns, D. S., McKenzie, A.F., Ware, R. E. H., A. and Ball, D. L., Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study, J. Clin. Oncol., 19: 111-118, 2007.
49. Malamitsi, J., Valotassiou, B., Iliadis, K., Kosmidis, P., Paspas, F., Vasilaki, M., Pipini, E., Petounis, A., Gogou, L., Pagou, M., Dalianis, K., Efthimiadou, R. and Andreou, J., Preliminary Results on The Role of PET/CT in Initial Staging, Restaging and Management of Lung Cancer, Nucl. Instr. Meth. Phys. Res, 569:319-322, 2006.
50. Fischer, B. M., Mortensen, J., Langer, S. W., Loft, A., Berthelsen, A. K., Daugaard, G., Lassen, U. and Hansen, H. H., PET/CT imaging in response evaluation of patients with small cell lung cancer, Lung Cancer, 54: 41-49, 2006.
51. Schoder, H., Yeung, H. W. D., Gonen, M., Kraus, D. and Larson, S. M., Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion, Radiol., 231: 65-72, 2004.
52. Yau, Y.-Y., Samman, N. and Yeung, R. W. K., Positron emission tomography/computed tomography true fusion imaging in clinical head and neck oncology: Early experience, J. Oral. Maxillofac. Surg., 63: 479-486, 2005.
53. Zimmer, L. A., McCook, B., Melter, C., Fukui, M., Bascom, D., Synderman, C., Townsend, D. W. and Johnson, J. T., Combined positron emission tomography/computed tomography imaging of recurrent thyroid cancer, Otolaryngology - Head and Neck Surgery, 128: 178-184, 2003.
54. Schoder, H., Carlson, D. L., Kraus, D. H., Stambuk, H. E., Gonen, M., Erdi, Y. E., Yeung, H. W. D., Huvos, A. G., Shah, J. P., Larson, S. M. and Wong, R. J., 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged NO by clinical examination and CT/ MRI, J. Nucl. Med., 47: 755-762, 2006.
55. Schwartz, D. L., Ford, E., Rajendran, J., Yueh, B., Coltera, M. D., Virgin, J., Anzai, Y., Haynor, D., Lewellyn, B., Mattes, D., Meyer, J. and Phillips, M., FDG-PET CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma, Int. J. Radiat. Oncol. Biol. Phys., 61: 129-136, 2005.
56. Goerres, G. W., von Schulthess, G. K. and Steinert, H. C., Why most PET of lung and head-and-neck cancer will be PET/CT, J. Nucl. Med. (suppl), 45: 66S-71S, 2004.
57. Fukui, M. B., Blodgett, T. M. and Meltzer, C. C., PET/CT imaging in recurrent head and neck cancer, Semin. Uttrasound CT MRI, 24: 157-163, 2003.
58. Connell, C. A., Corry, J., Milner, A. D., Hogg, A., Hicks, R. J., Rischin, D. and Peters, L. J., Clinical impact of and prognostic stratification by, F-18 FDG PET/CT in head and neck mueosal squamous cell carcinoma, Head & Neck, 29: 986-995, 2007.
59. Rosenbaum, S. J., Stergar, H., Antoch, G., Veit, P., Bockisch, A. and Kühl, H., Staging and follow-up of gastrointestinal tumours with PET/CT, Abdom. Imaging, 31: 23-35, 2005.
60. Schoder, H., Larson, S. M. and Yeung, H. W. D., PET/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies, J. Nucl. Med. (suppl), 45: 72S-81S, 2004.
61. Wechalekar, K., Sharma, B. and Cook, G., PET/CT in Oncology - A Major Advance, Clin. Radiol., 60: 1143-1155, 2005.
62. Antoch, G., Kanja, J., Bauer, S., Kuehl, H., Renzing-Koehler, K., Schuette, J., Bockisch, A., Debatin, J. F. and Freudenberg, L. S., Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors, J. Nucl. Med., 45: 357-365, 2004.
63. Goerres, G. W., Stupp, R., Barghouth, G., Hany, T. F., Pestalozzi, B., Dizendorf, E., Schnyder, P., Luthi, F., von Schulthess, G. K. and Leyvraz, S., The value of PEZ CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylate, Eur. J. Nuc. Med. Mol. Imag., 32: 153-162, 2005.
64. Cohade, C., Osman, M., Leal, J. and Wahl, R. L., Direct Comparison of 18F-FDG PET and PET/CT in Patients with Colorectal Carcinoma, J. Nucl. Med., 44: 1797, 2003.
65. Even-Sapir, E., Parag, Y., Lerman, H., Gutman, M., Levine, C., Rabau, M., Figer, A. and Metser, U., Detection of Recurrence in Patients with Rectal Cancer: PET/CT After Abdominoperineal or Anterior Resection, Radiol., 232: 815-822, 2004.
66. Cohn, D. E., Dehdashti, F., Gibb, R. K., Mutch, D. G., Rader, J. S., Siegel, B. A. and Herzog, T. J., Prospective Evaluation of Positron Emission Tomography for the Detection of Groin Node Metastases from Vulvar Cancer, Gynecol. Onc., 85: 179-184, 2002.
67. Nakamoto, Y., Eisbruch, A., Achtyes, E. D., Sugawara, Y., Reynolds, K. R., Johnston, C. M. and Wahl, R. L., Prognostic Value of Positron Emission Tomography Using F-18-Fluorodeoxyglucose in Patients with Cervical Cancer Undergoing Radiotherapy, Gynecol. Onc., 84: 289-295, 2002.
68. Horowitz, N. S., Dehdashti, F., Herzog, T. J., Rader, J. S., Powell, M. A., Gibb, R. K., Grigsby, P. W., Siegel, B. A. and Mutch, D. G., Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer, Gynecol. Onc., 95: 546-551, 2004.
69. Lamoreaux, W. T., Grigsby, P. W., Dehdashti, F., Zoberi, I., Powell, M. A., Gibb, R. K., Rader, J. S., Mutch, D. G. and Siegel, B. A., FDG-PET evaluation of vaginal carcinoma, Int. J. Radiat. Oncol. Brit., 62: 733-737, 2005.
70. Makhija, S., Howden, N., Edwards, R., Kelley, J., Townsend, D. W. and Meltzer, C. C., Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review, Gynecol. Onc., 85: 53-58, 2002.
71. Grisaru, D., Almog, B., Levine, C., Metser, U., Fishman, A., Lerman, H., Lessing, J. B. and Even-Sapir, E., The diagnostic accuracy of 18F-fluorodeoxyglucose PET/CT in patients with gynaecological malignancies, Gynecol. Onc., 94: 680-684, 2004.
72. Wahl, R., Why nearly all PET of abdominal and pelvic cancers will be performed as PET/CT, J. Nucl. Med. (suppl), 45: 82S-95S, 2004.
73. Simcock, B., Neesham, D., Quinn, M., Drummond, E., Milner, A. and Hicks, R. J., The impact of PET/CT in the management of recurrent ovarian cancer, Gynecol. Onc., 103: 271-276, 2006.
74. Zangheri, B., Messa, C., Picchio, M., Gianolli, L., Landoni, C. and Fazio, F., PET/CT and breast cancer, Eur. J. Nucl. Med. Mol. Imag. (suppl), 31: S135-S142, 2004.
75. Tatsumi, M., Cohade, C., Mourtzikos, K., Fishman, E. K. and Wahl, R., Initial experience with FDG PET/CT in the evaluation of breast cancer, Eur. J. Nucl. Med. Mol. Imag., 33: 254-262, 2006.
76. Du, Y., Cullum, I., Illidge, T. M. and Ell, P. J., Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer, J. Clin. Oncol., 25: 3440-3447, 2007.
77. Cachin, F., Prince, H. M., Hogg, A., Ware, R. E. and Hicks, R. J., Powerful prognostic stratification by [18F]fluorodeoxyglucose positron emission tomography in patients with metastatic breast cancer treated with high-dose chemotherapy, J. Clin. Oncol., 24: 3026-3031, 2006.
78. Radan, L., Ben-Haim, S., Bar-Shalom, R., Guralnik, L. and Israel, O., The role of FDG-PET/CT in suspected recurrence of breast cancer, Cancer, 107: 2545-2551, 2006.
79. Picchio, M., Messa, C., Landoni, C., Gianolli, L., Sironi, S. and Brioschi, M., Value of [11C] Choline Positron Emission Tomography for Re-Staging Prostate Cancer: A Comparison with [18F] Fluorodeoxyglucose-Positron Emission Tomography, J. Urol., 169: 1337-1340, 2003.
80. Reske, S. N., Blumstein, N. M., Neumaier, B., Gottfried, H. W., Finsterbusch, F., Kocot, D., Möller, P., Glatting, G. and Perner, S., Imaging Prostate Cancer with 11C-Choline PET/CT, J. Nucl. Med., 47: 1249-1254, 2006.
81. Kwee, S. A., Wei, H., Sesterhenn, I., Yun, D. and Coel, M. N., Localization of Primary Prostate Cancer with Dual-Phase 18F-fluorocholine PET, J. Nucl. Med., 47: 262-269, 2006.
82. Segall, G. M., FDG PET Imaging in Patients with Lymphoma: A Clinical Perspective, J. Nucl. Med., 42: 609-610, 2001.
83. Hany, T. F., Steinert, H. C., Goerres, G. W., Buck, A. and von Schulthess, G. K., PET Diagnostic Accuracy: lmprovement with In-Line PET-CT System: Initial Results, Radiol., 225: 575-581, 2002.
84. Israel, O., Mor, M., Gaitini, D., Keidar, Z., Guralnik, L., Engel, A., Frenkel, A., Bar-Shalom, R. and Kuten, A., Combined Functional and Structural Evaluation of Cancer Patients with a Hybrid Camera-Based PET/ CT System Using 18F-FDG, J. Nucl. Med., 43: 1129-1136, 2002.
85. Charron, M., Beyer, T., Bohnen, N. N., Kinahan, P. E., Dachille, M., Jerin, J., Nutt, R., Meltzer, C. C., Villemagne, V. L. and Townsend, D. W., Image analysis in oncology patients studied with a combined PET/ CT scanner, Clin. Nucl. Med., 25: 905-910, 2000.
86. Tatsumi, M., Cohade, C., Nakamoto, Y., Fishman, E. K. and Wahl, R. L., Direct Comparison of FDG PET and CT Findings in Patients with Lymphoma: Initial Experience, Radiol., 237: 1038-1045, 2005.
87. Rodriguez, V. B., Gomez, L. N., Pinilla, I., Hernandez, M. D., Coya, J. and Martin, C. L., Positron emission tomography/computed tomography in the management of Hodgkin's disease and non-Hodgkin's lymphoma, Curr. Probl. Diagn. Radiol., 35: 151-63, 2006.
88. Schaefer, N. G., Hany, T. F., Taverna, C., Seifert, B., Stumpe, K. D. M., von Schulthess, G. K. and Goerres, G. W., Non-Hodgkin Lymphoma and Hodgkin Disease: Coregistered FDG PET and CT at Staging and Restaging-Do We Need Contrast-enhanced CT?, Radiol., 232: 823-829, 2004.
89. Freudenberg, L. S., Antoch, G., Schutt, P., Beyer, T., Jentzen, W., Muller, S. P., Gorges, R., Nowrousian, M. R., Bockisch, A. and Debatin, J. F., FDG-PET/CT in re-staging of patients with lymphoma, Eur. J. Nucl. Med. Mol. Imag., 31: 325-329, 2004.
90. Metser, U., Lerman, H., Blank, A., Lievshitz, G., Bokstein, F. and Even-Sapir, E., Malignant Involvement in the Spine: Assessment by 18F-FDG PET/CT, J. Nucl. Med., 45: 279-284, 2004.
91. Gutzeit, A., Antoch, G., Kühl, H., Egelhof, T., Fischer, M., Hauth, E., Goehde, S., Bockisch, A., Debatin, J. and Freudenberg, L., Unknown Primary Tumours: Detection with Dual-Modality PET/CT - Initial Experience, Radiol., 234: 227-234, 2005.
92. Israel, O., Mor, M., Guralnik, L., Hermoni, N., Gaitini, D., Bar-Shalom, R., Keidar, Z. and Epelbaum, R., Is 18F-FDG PET/CT Useful for Imaging and Management of Patients with Suspected Occult Recurrence of Cancer, J. Nucl. Med., 45: 2045-2051, 2004.
93. King, G., PET-CT alters management of patients with gynecologic cancers, ASCO Proc., May 18-21, Orlando, Florida, 2002.
94. Mac Manus, M., Hicks, R. J. and Everitt, S., Role of PET-CT in the optimization of thoracic radiotherapy, J. Thorac. Oncol., 1: 81-84, 2006.
95. Hicks, R. J. and Mac Manus, M. P., 18F-FDG PET in candidates for radiation therapy: is it important and how do we validate its impact?, J. Nucl. Med., 44: 2003.
96. Ciernik, I. F., Dizendorf, E., Baumert, B. G., Reiner, B., Burger, C., Davis, J. B., Lutolf, U. M., Steinert, H. C. and von Schulthess, G. K., Radiation Treatment Planning with An Integrated Positron Emission and Computer Tomography (PET/CT): A Feasibility Study, Int. J. Radiat. Oncol. Biol. Phys., 57: 853-863, 2003.
97. Paulino, A. C., Koshy, M., Howell, R., Schuster, D. and Davis, L. W., Comparison of CT- and FDG-PET-Defined Gross Tumor Volume in Intensity-Modulated Radiotherapy for Head-and-Neck Cancer, Int. J. Radiat. Oncol. Biol. Phys., 61: 1385-1392, 2005.
98. Ashamalla, H., Rafla, S., Parikh, K., Mokhtar, B., Goswani, G., Kambam, S., Abdel-Dayem, H., Guirguis, A., Ross, P. and Evola, A., The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer, Int. J. Radiat. Oncol. Biol. Phys., 63: 1016-1023, 2005.
99. Ashamalla, H., Guirguis, A., Bieniek, E., Rafla, S., Evola, A., Goswami, G., Oldroyd, R., Mokhtar, B. and Parikh, K., The Impact of Positron Emission Tomography/Computed Tomography in Edge Delineation of Gross Tumor Volume for Head and Neck Cancers, Int. J. Radiat. Oncol. Biol. Phys., 68: 388-395, 2007.
100. Gondi, V., Bradley, K., Mehta, M., Howard, A., Khuntia, D., Ritter, M. and Tomé, W., Impact of Hybrid Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography on Radiotherapy Planning in Esophageal and Non-Small Cell Lung Cancer, Int. J. Radiat. Oncol. Biol. Phys., 67: 187-195, 2007.
101. Heron, D. E., Andrade, R. S., Flickinger, J., Johnson, J., Agarwala, S. S., Wu, A., Kalnicki, S. and Avril, N., Hybrid PET-CT Simulation for Radiation Treatment Planning in Head and Neck Cancers: A Brief Technical Report, Int. J. Radiat. Oncol. Biol. Phys., 60: 1419-1424, 2004.
102. Wang, D., Schultz, C. J., Jursinic, P. A., Bialkowski, M., Zhu, X. R., Brown, W. D., Rand, S. D., Michel, M. A., Campbell, B. H., Wong, S., Li, X. A. and Wilson, F. W., Initial Experience of FDG-PET/CT Guided IMRT of Head-and-Neck Carcinoma, Int. J. Radiat. Oncol. Biol. Phys., 65: 143-151, 2006.
103. Bradley, J., Thorstad, W. L., Mutic, S., Miller, T. R., Dehdashti, F., Siegel, B. A., Bosch, W. and Bertrand, R. J., Impact of FDG-PET on Radiation Therapy Volume Delineation in Non-Small-Cell Lung Cancer, Int. J. Radiat. Oncol. Biol. Phys, 59: 78-86, 2004.
104. Biehl, K. J., Kong, F.-M., Dehdashti, F., Jin, J.-Y., Mutic, S., El Naqa, I., Siegel, B. A. and Bradley, J. D., 18F-FDG PET Definition of Gross Tumor Volume for Radiotherapy of Non-Small Cell Lung Cancer: Is a Single Standardized Uptake Value Threshold Approach Appropriate?, J. Nucl. Med., 47: 1808-1812, 2006.
105. Nestle, U., Kremp, S. and Grosu, A.-L., Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): The technical basis, ICRU-target volumes, problems, perspectives, Rad. Onc., 81: 209-225, 2006.
106. Grégoire, V., Haustermans, K., Geets, X., Roels, S. and Lonneux, M., PET-Based Treatment Planning in Radiotherapy: A New Standard?, J. Nucl. Med. (suppl), 48: 68S-77S, 2007.
107. Riegel, A. C., Berson, A. M., Destian, S., Ng, T., Tena, L. B., Mitnick, R. J. and Wong, P. S., Variability of gross tumour volume delineation in head-and-neck cancer using CT and PET/CT, Int. J. Radiat. Oncol. Biol. Phys, 65: 726-32, 2006.
108. Ling, C. C., Humm, J., Larson, S., Amols, H., Fuks, Z., Leibel, S. and Koutcher, J. A., Towards multidimensional radiotherapy (MD-CRT): Biological Imaging and Biological Conformity, Int. J. Radiat. Oncol. Biol. Phys., 47: 551-560, 2000.
109. Søvik, A., Malinen, E., Skogmo, H. K., Bentzen, S. M., Bruland, O. S. and Olsen, D. R., Radiotherapy Adapted to Spatial and Temporal Variability in Tumor Hypoxia, Int. J. Radiat. Oncol. Biol. Phys., 68: 1496-1504, 2007.
110. Vanderstraeten, B., Duthoy, W., De Gersem, W., De Neve, W. and Thierens, H., [18F] fluoro-deoxy-glucose positron emission tomography ([18F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer, Rad. Onc., 79: 249-258, 2006.
111. Ell, P. J., The contribution of PET/CT to improved patient management, BJR., 79: 32-26, 2006.
112. von Schulthess, G. K., Steinert, H. C. and Hany, T. F., Integrated PET/CT: Current applications and future directions, Radiobiology, 238: 405-422, 2006.
113. Kapuco, L. O., Meltzer, C. C., Townsend, D. W., Keenan, R. J., Luketich and J.D., Fluorine-18-fluorodeoxyglucose uptake in pneumonia, J. Nucl. Med., 39: 1267-1269, 1998.
114. Bakheet, S. M., Powe, J., Ezzat, A. and Roston, A., F-18-FDG uptake in tuberculosis, Clin. Nucl. Med., 23: 739-742, 1998.
115. Bakheet, S. M., Powe, J., Kandil, A., Ezzat, A., Rostom, A. and Amartey, J., F-18-FDG uptake in breast infection and inflammation, Clin. Nucl. Med., 25: 100-103, 2000.
116. Gysen, M., Stroobants, S. and Mortelmans, L., Proliferative myositis: a case of a pseudomalignant process, Clin. Nucl. Med., 23: 836-838, 1998.
117. Yasuda, S., Shohtsu, A., Ide, M., Takagi, S., Kijima, H. and Horiuchi, M., Elevated F-18 FDG uptake in plasmacyte-rich chronic maxillary sinusitis, Clin. Nucl. Med., 23: 176-178, 1998.
118. Brudin, L. H., Valind, S.-O., Rhodes, C. G., Panting, C. F., Sweatmang, M., Jones, T. and Hughes, J. M. B., Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography, Eur. J. Nucl. Med. Mol. Imag., 21: 297-305, 1994.
119. Tahara, T., Ichiya, Y., Kuwabara, Y., Otsuka, M., Miyake, Y., Gunasekera, R. and Masuda, K., High [18F]-fluorodeoxyglucose uptake in abdominal abscesses: a PET study, J. Comput. Assist. Tomogr., 13: 829-831, 1989.
120. Crymes, W. B., Demos, H. and Gordon, L., Detection of musculoskeletal infection with 18F-FDG PET: Review of the current literature, J. Nucl. Med. Technol., 32: 12-15, 2004.
121. Stumpe, K. D. M. and Strobel, K., 18F FDG PET imaging in musculoskeletal infection, Q. J. Nucl. Med. Mol. Imaging., 50: 131-142, 2006.
122. Keidar, Z., Militianu, D., Melamed, E., Bar-Shalom, R. and Israel, O., The diabetic foot: initial experience with 18F-FDG PET/CT, J. Nucl. Med., 46: 444-449, 2005.
123. Schiesser, M., Stumpe, K. D. M., Trentz, O., Kossmann, T., Schulthess, v. and G.K., Detection of metallic implant-associated infections with FDG PET in patients with trauma: correlation with microbiologic results, Radiol., 226: 391-398, 2003.
124. Meller, J., Sahlmann, C. O. and Scheel, A. K., 18F-FDG PET and PET/CT in fever of unknown origin, J. Nucl. Med., 48: 35-45, 2007.
125. Kaufmann, P. A. and Camici, P. D., Myocardial blood flow measurement by PET: Technical aspects and clinical applications, J. Nucl. Med., 46: 77-88, 2005.
126. Koepfli, P., Hany, T. F., Wyss, C. A., Namdar, M., Burger, C., Konstantinidis, A. V., Berthold, T., von Schulthess, G. K. and Kaufmann, P. A., CT attenuation correction for myocardial perfusion quantification using a hybrid PET/CT scanner, J. Nucl. Med., 45: 537-542, 2004.
127. Lodge, M. A., Braess, H., Mahmoud, F., Suh, J., Englar, N., Geyser-Stoops, S., Jenkins, J., Bacharach, S. L. and Dilsizian, V., Review: Developments in nuclear cardiology: Transition from single photon emission computed tomography to positron emission tomography/ computed tomography, J. Invasive Cardiol., 17: 491-496, 2005.
128. Schwaiger, M., Ziegler, S. and Nekolla, S. G., PET/CT: Challenge for nuclear cardiology, J. Nucl. Med., 46: 1664-1678, 2005.
129. Tatsumi, M., Cohade, C., Nakamoto, Y. and Wahl, R. L., Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis, Radiol., 229: 831-839, 2003.
130. Wagner, B., Anton, M., Nekolla, S. G., Reder, S., Henke, J., Seidl, S., Hegenloh, R., Miyagawa, M., Haubner, R., Schwaiger, M. and Bengel, F. M., Noninvasive Characterization of Myocardial Molecular Interventions by Integrated Positron Emission Tomography and Computed Tomography, J. Am. Coll. Cardiol., 48: 2107-2115, 2006.
131. Townsend, D. W., Beyer, T. and Blodget, T. M., PET/CT scanners: A hardware approach to image fusion, Semin. Nucl. Med., 33: 193-204, 2003.
132. Brianzoni, E., Rossi, G., Ancidei, S., Berbellini, A., Capoccetti, F., Cidda, C., D'Avenia, P., Fattori, S., Montini, G. C., Valentini, G. and Proietti, A., Radiotherapy planning: PET/CT scanner performances in the definition of gross tumour volume and clinical target volume, Eur. J. Nucl. Med. Mol. Imag., 32: 1392-1399, 2005.
133. Shim, S. S., Lee, K. S., Kim, B.-T., Chung, M. J., Lee, E. J., Han, J., Choi, J. Y., Kwon, O. J., Shim, Y. M. and Kim, S., Non-Small Cell Lung Cancer: Prospective Comparison of Integrated FDG PET/CT and CT Alone for Preoperative Staging, Radiol., 236: 1011-1019, 2005.
134. Kim, Y. K., Lee, K. S., Kim, B.-T., Choi, J. Y., Kim, H., Kwon, O. J., Shim, Y. M., Yi, C. A., Kim, H. Y. and Chung, M. J., Mediastinal Nodal Staging of Nonsmall Cell Lung Cancer Using Integrated 18F-FDG PET/ CT in a Tuberculosis-Endemic Country: Diagnostic Efficacy in 674 Patients, Cancer, 109: 1068-1077, 2007.
135. Ha, P. K., Hdeib, A., Goldenberg, D., Jacene, H., Patel, P., Koch, W., Califano, J., Cummings, C. W., Flint, P. W., Wahl, R. and Tufano, R. P., The role of positron emission tomography and computed tomography fusion in the management of early-stage and advanced-stage primary head and neck squamous cell carcinoma, Arch. Otolaryngol. Head Neck Surg., 132: 12-16, 2006.
136. Breen, S. L., Publicover, J., De Silva, S., Pond, G., Brock, K., O'Sullivan, B., Cummings, B., Dawson, L., Keller, A., Kim, J., Ringash, J., Yu, E., Hendler, A. and Waldron, J., Intraobserver and interobserver variability in GTV delineation on FDG-PET-CTimages of head and neck cancers, Int. J. Radiat. Oncol. Biol. Phys., in press.
137. Murakami, R., Uozumi, H., Hirai, T., Nishimura, R., Shiraishi, S., Ota, K., Murakami, D., Tomiguchi, S., Oya, N., Katsuragawa, S. and Yamashita, Y., Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma, Int. J. Radiat. Oncol. Biol. Phys., 68: 377-382, 2007.
138. Israel, O., Yefremov, N., Bar-Shalom, R., Kagana, O., Frenkel, A., Keidar, Z. and Fischer, D., PET/CT Detection of Unexpected Gastrointestinal Foci of 18F-FDG Uptake: Incidence, Localization Patterns, and Clinical Significance, J. Nucl. Med., 46: 758-762, 2005.
139. Bar-Shalom, R., Guralnik, L., Tsalic, M., Leiderman, M., Frenkel, A., Gaitini, D., Ben-Nun, A., Keidar, Z. and Israel, O., The additional value of PET/CT over PET in FDG imaging of oesophageal cancer, Eur. J. Nucl. Med. Mol. Imaging, 32: 918-924, 2005.
140. Kim, J.-H., Czernin, J., Allen-Auerbach, M. S., Halpern, B. S., Fueger, B. J., Hecht, J. R., Ratib, O., Phelps, M. E. and Weber, W. A., Comparison between 18F-FDG PET, in-line PET/CT, and software fusion for restaging of recurrent colorectal cancer, J. Nucl. Med., 46: 587-595, 2005.
141. Veit-Haibach, P., Kuehle, C. A., Beyer, T., Stergar, H., Kuehl, H., Schmidt, J., Borsch, G., Dahmen, G., Barkhausen, J., Bockisch, A. and Antoch, G., Diagnostic Accuracy of Colorectal Cancer Staging With Whole-Body PET/CT Colonography, JAMA, 296: 2590-2600, 2006.
142. Choi, H. J., Roh, J. W., Seo, S.-S., Lee, S., Kim, J.-Y., Kim, S.-K., Kang, K. W., Lee, J. S., Jeong, J. Y. and Park, S.-Y., Comparison of the Accuracy of Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Presurgical Detection of Lymph Node Metastases in Patients with Uterine Cervical Carcinoma, Cancer, Cancer, 106: 914-922, 2006.
143. Veit-Haibach, P., Antoch, G., Beyer, T., Stergar, H., Schleucher, R., Hauth, E. A. M. and Bockisch, A., FDG-PET/CT in restaging of patients with recurrent breast cancer: possible impact on staging and therapy, BJR, 80: 508-515, 2007.
144. Piperkova, E., Raphael, B., Altinyay, M. E., Castellon, I., Libes, R., Sandella, N., Heiba, S. and Abdel-Dayem, H., Impact of PET/CT in Comparison With Same Day Contrast Enhanced CT in Breast Cancer Management, Clin. Nucl. Med., 32: 429-434, 2007.
145. Schmid, D. T., John, H., Zweifel, R., Cservenyak, T., Westera, G., Goerres, G. W., von Schulthess, G. K. and Hany, T. F., Fluorocholine PET/CT in patients with prostate cancer: initial experience, Radiol., 235: 623-628, 2005.
146. Raanani, P., Shasha, Y., Perry, C., Metser, U., Naparstek, E., Apter, S., Nagler, A., Polliack, A., Ben-Bassat, I. and Even-Sapir, E., Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era?, Annals of Oncology, 17: 117-122, 2006.